You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

先聲藥業(02096.HK)獲執行董事萬玉山增持7萬股

格隆匯 04-29 08:01

格隆匯APP獲悉,根據聯交所最新權益披露資料顯示,2022年4月25日,先聲藥業(02096.HK)獲執行董事萬玉山在場內以每股均價7.9571港元增持7萬股,涉資約55.7萬港元。

增持後,萬玉山最新持股數目為215.5萬股,持股比例為0.08%。

20220808先聲藥業02096
Relevant Stocks